Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Myasthenia Gravis × Mycophenolic Acid × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1 INDIV 1 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Mycophenolic Acid 1 Immunoglobulins 1 Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00285350 2015-03-25

Mycophenolate Mofetil in Myasthenia Gravis

FDA Office of Orphan Products Development

Phase 3 Completed

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡